Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Paulette Mhawech-FaucegliaFrançois R Herrmann

Abstract

The study was designed to evaluate Raf1, Aurora-A/STK15 and E-cadherin (E-CD) protein expression and their prognostic value in patients with pTa/pT1 tumours. A tissue microarray of 105 pTa, and 141 pT1 tumours was constructed and sections were immunostained with these three antibodies. There were significant associations between Raf1 overexpression and tumour grade (p = 0.03), between Aurora-A overexpression/alterations of E-CD and tumour grade and stage (p < 0.001 and p < 0.001). In multiple Cox regression analysis, moderate/strong expression of E-CD seemed to be an independent factor in predicting slower tumour progression (p = 0.003) and Aurora-A overexpression (p = 0.022) displays an independent value in predicting tumour recurrences. Evaluation of E-CD and Aurora-A expressions in tissue of patients with pTa/pT1 UC have been proven to be useful in predicting tumours behavior and Raf1 protein expression seemed to have no potential use in this regard.

References

Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Aug 24, 1999·The Journal of Urology·S HolmängS L Johansson
May 13, 2003·Cell Motility and the Cytoskeleton·D L StenoienB R Brinkley
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yung-Ming JengHey-Chi Hsu
Sep 17, 2004·Pathology·Beena KumarJane E Armes
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yoshiaki YamamotoKatsusuke Naito
Jan 8, 2005·The Canadian Journal of Urology·Laurence H Klotz
Jun 10, 2005·FEBS Letters·Manuela Baccarini

❮ Previous
Next ❯

Citations

Oct 26, 2006·World Journal of Urology·Christopher Y Thomas, Dan Theodorescu
May 7, 2010·Current Oncology Reports·Arlene Siefker-Radtke
Sep 21, 2010·Pathology Oncology Research : POR·Apostolos ZaravinosDemetrios A Spandidos
Dec 14, 2011·Nature Reviews. Urology·George J Netto
Oct 9, 2008·Annual Review of Pathology·Anirban P Mitra, Richard J Cote
Mar 31, 2012·Archives of Pathology & Laboratory Medicine·George J Netto, Liang Cheng
Feb 14, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ning ZhouDonna E Hansel
Jul 19, 2014·Critical Reviews in Clinical Laboratory Sciences·Francesca SanguedolceLuigi Cormio
Dec 1, 2012·Surgical Pathology Clinics·George J Netto
Jun 20, 2008·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·D-C LinM-R Wang
Jul 1, 2008·Proteomics. Clinical Applications·Pavel GromovJulio E Celis
Jan 31, 2015·Targeted Oncology·Francesco MassariGiampaolo Tortora
Apr 21, 2011·Scandinavian Journal of Urology and Nephrology·Sigurdur GudjónssonFredrik Liedberg
Apr 2, 2015·Cancer Treatment Reviews·Emmanuel Seront, Jean-Pascal Machiels
Feb 25, 2014·World Journal of Urology·Michela de MartinoTobias Klatte
Aug 3, 2007·Journal of Biomedical Materials Research. Part a·Roche C de Guzman, Pamela J VandeVord

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.